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Relation Between Central Venous, Peripheral Venous  
and Arterial Lactate Levels in Patients With Sepsis  
in the Emergency Department
Dimitrios Velissarisa, b, Vasileios Karamouzosc, Nikolaos Dimitrios Pantzarisd,  
Ourania Kyriakopouloub, Charalampos Gogosa, 
 Menelaos Karanikolase, f
Abstract
Background: Sepsis and multi-organ failure remain a major clinical 
problem with high morbidity and mortality worldwide. Lactate meas-
urement remains part of the initial assessment and management of 
patients with sepsis. Although arterial blood is most commonly used 
for lactate measurement, there is increasing use of peripheral venous 
lactate for initial assessment and for monitoring of response to treat-
ment in patients with sepsis. The aim of this study was to evaluate the 
relation between lactate levels measured from central line, peripheral 
vein and arterial line in patients treated for sepsis in the emergency 
department (ED).
Methods: This prospective study enrolled 31 patients with diagnosis 
of sepsis who were evaluated and treated in the ED of a university 
hospital. During initial resuscitation, blood samples from the artery, 
peripheral vein and central vein (when available) were collected and 
lactate concentrations were measured. Correlation between lactate 
values from the three different locations was assessed using Pearson 
correlation. Bland-Altman plots were used to evaluate agreement be-
tween lactate measurements in different sampling locations. All pa-
tients were eventually admitted to the Internal Medicine Department 
ward or to the intensive care unit (ICU) for further treatment.
Results: Our data showed strong, highly significant correlation be-
tween arterial and peripheral venous lactate levels (r = 0.880, P < 
0.0001), between arterial and central venous blood lactate (r = 0.898, 
P < 0.0001) and between central and peripheral venous blood lactate 
(r = 0.941, P < 0.0001).
Conclusions: In this study we observed strong correlation between 
arterial, central vein and peripheral vein lactate concentrations in 31 
patients assessed and treated for sepsis. We suggest that lactate meas-
urement in peripheral venous blood could be used for screening and for 
monitoring response to therapy in sepsis patients. However, because 
this is a small study in only 31 patients and published data are limited, 
larger studies are needed in order to confirm the validity of our findings.
Keywords: Sepsis; Arterial lactate; Peripheral venous lactate; Central 
venous lactate; Monitoring; Resuscitation
Introduction
Sepsis and the resulting multi-organ failure are still associated 
with high morbidity and mortality rates [1]. The management 
of patients with sepsis should begin in the emergency depart-
ment (ED) in accordance with the international guidelines of 
the Surviving Sepsis Campaign [2]. Serial lactate concentra-
tion measurements are helpful in evaluating the progression of 
sepsis and can guide decision-making by clinicians.
Most clinicians use arterial blood samples to measure lac-
tate levels. However, in the ED setting and especially in con-
scious patients, arterial puncture causes patient discomfort and 
also has a small risk of arterial injury or other complications, 
including thrombosis and ischemia [3]. As an alternative to arte-
rial sampling, clinicians sometimes use repeated lactate meas-
urements via peripheral or central veins when available, and pe-
ripheral venous lactate sampling has been used as part of routine 
blood testing in some cases [4, 5]. However, only a few studies 
have evaluated the role of venous blood lactate measurements 
as alternative to arterial blood sampling. The aim of this study 
is to evaluate the interchangeability of the arterial blood lactate 
with the peripheral venous lactate and the central venous lactate 
(CV-lactate) in patients with sepsis treated in the ED.
Materials and Methods
This prospective study was conducted in the Emergency 
Department of the University Hospital of Patras, in Western 
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Greece, between November 2017 and May 2018 and enrolled 
31 patients. Inclusion criteria were age > 18 years and diagno-
sis of sepsis of any origin confirmed by clinical examination, 
laboratory tests, radiographic findings (e.g. chest X-ray) or any 
other intervention performed in the ED.
Exclusion criteria were known liver or renal failure, and 
metformin use. The diagnosis of sepsis was established ac-
cording to the recently published Third International Consen-
sus Definitions for Sepsis and Septic Shock (Sepsis-3) defi-
nitions criteria [6]. All patients were assessed and treated in 
the resuscitation room of the ED in accordance with the initial 
resuscitation guidelines of the Surviving Sepsis Campaign [2].
A central line was inserted in patients with poor peripheral 
access and in patients who required support with continuous 
infusion of vasopressors for resuscitation purposes. Three sepa-
rate blood samples were simultaneously obtained from central 
and peripheral veins and arterial sampling for lactate analysis. 
All blood samples were immediately analyzed in a point of care 
blood gas analyzer (Stat Profile pHOx Ultra TM/CCXTMLactate 
Membrane Kit, NOVA BIOMEDICAL, Waltham, MA, USA).
The study was conducted in compliance with the ethical 
standards of the responsible institution on human subjects and 
with the Helsinki Declaration. The study protocol was ap-
proved by the Institutional Review Board of the University 
Hospital. All patients (or their legal guardian) gave written 
informed consent before enrolling in the study. Data collect-
ed for the study were anonymized and stored in an encrypted 
electronic database. The medical team involved in the study 
included University of Patras faculty, resident physicians rotat-
ing through the ED and outside consultants.
Statistical analysis
All patient data were anonymized, entered in a secure elec-
tronic database and stored in a secure, encrypted personal 
computer. Data were analyzed using the MedCalc Statistical 
Software version 18.11.6 (MedCalc Software bvba, Ostend, 
Belgium; https://www.medcalc.org; 2019). Normality of data 
distribution was assessed using the Kolgomorov-Smirnov test. 
Repeated measures analysis of variance (ANOVA) was used to 
compare lactate levels in arterial blood versus peripheral vein 
versus central vein samples, and paired t-test was used for post 
hoc analysis when indicated.
Correlation between lactate values from the three different 
locations was assessed using Pearson correlation. When cor-
relations were significant, linear regression analysis was con-
ducted in order to assess how well the values of one variable 
(on the X axis) can predict the values of the other variable 
(on the Y axis). Data are presented as mean ± standard devia-
tion (SD) or as median (min, max) as appropriate. P < 0.05 
was considered statistically significant for all analysis. Bland-
Altman plots were generated to evaluate agreement in lactate 
measurements between the three different sampling locations.
Results
In total, 31 patients were included in the study. Data were col-
lected from 31 patients, 13 men and 18 women. Patient age 
was 75.1 ± 9.7 for men versus 79.1 ± 14 for women, and there 
were no significant differences between men and women. Lac-
tate levels were measured in arterial blood in 26 patients, in 
central venous blood in 16 patients and in peripheral venous 
blood in 29 patients. As a result, we could compare and cor-
relate arterial versus peripheral vein samples in 26 patients, but 
we had data from all three sources in only 13 patients.
Comparison between variables using repeated measures 
ANOVA showed that there was no significant difference be-
tween lactate levels in arterial (3.08 ± 1.56) versus peripheral 
venous (3.1 ± 1.78) versus central venous blood (3.22 ± 1.92, 
P > 0.8, Fig. 1).
There was very strong, highly significant correlation be-
tween arterial and peripheral venous lactate levels (Pearson’s 
r = 0.880, P < 0.0001), between arterial and central venous 
blood (Pearson’s r = 0.898, P < 0.0001) and between central 
and peripheral venous blood (Pearson’s r = 0.941, P < 0.0001). 
Results of correlation analysis for lactate concentrations in dif-
ferent samples are summarized in Table 1.
Regression analysis showed that lactate concentration in 
peripheral vein blood is a strong, highly significant but im-
perfect predictor of lactate concentration in arterial blood (r 
= 0.88, P < 0.001, Fig. 2a) and in central venous blood (r = 
0.94, P < 0.001, Fig. 2b). Regression analysis also showed that 
lactate concentration in central vein blood is a strong, highly 
significant but imperfect predictor of lactate concentration in 
arterial blood (r = 0.90, P < 0.001, Fig. 2c).
Bland-Altman plot analysis showed good agreement be-
tween lactate concentration in central vein and that in peripher-
al vein (Fig. 3a), between lactate concentration in central vein 
and that in arterial blood (Fig. 3b), and between lactate con-
centration in peripheral vein and that in arterial blood (Fig. 3c).
Discussion
The sepsis syndrome has complex underlying pathophysiol-
ogy with severe cellular and metabolic abnormalities leading 
to cellular metabolism imbalance resulting in increased lactate 
production [7]. When tissue hypoxia exists, lactate is over-
produced due to increased anaerobic glycolysis, while lactate 
clearance occurs mostly in the liver (60%), followed by the 
kidney (30%). The lactate clearance cannot overcome the in-
creased lactate production during the critically ill status. Be-
cause liver dysfunction and kidney injury elevate lactate levels 
due to decreased lactate clearance, we exclude patients with 
these underlying conditions from our study.
Blood lactate levels can be used as marker for systemic 
tissue hypoperfusion and disease severity in sepsis: in one 
large retrospective study from the Netherlands, a 24-h mean 
lactate > 2 mmol/L was a strong predictor of intensive care unit 
(ICU) mortality [8], and the range of lactate values reported in 
this study were quite similar to the lactate values reported in 
our study.
Serum lactate concentration is included in the criteria for 
septic shock defined in Sepsis-3 [6]. Lactate level > 2 mmol/L 
(18 mg/dL) after adequate fluid resuscitation and the need for 
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vasopressor therapy in order to maintain mean arterial pressure 
> 65 mm Hg characterize septic shock [6, 9]. Most published 
research has focused on lactate level measurements using arte-
rial blood sampling in ED patients with sepsis. However, in the 
newer definition of septic shock, venous blood lactate levels 
seem to accurately reflect the abnormal cell-based metabolism 
and lactate levels can be considered as emerging vital signs 
[10].
In this prospective observational single center study, we 
saw a strong, clinically relevant and statistically highly signifi-
cant correlation between lactate levels measured in the periph-
eral artery, central and peripheral veins during initial resuscita-
tion in patients with sepsis. These results are in agreement with 
the findings of a prospective observational study published by 
Datta et al in 2018, which demonstrated good agreement be-
tween arterial lactate and peripheral lactate levels when lac-
tate levels were > 2 mmol/L in 304 patients with sepsis [11]. 
Strengths of our study include prospective study design and 
biologically plausible, highly significant, clinically relevant 
results. Limitations of our study include the small sample size 
and the fact that we did not categorize patients based on a spe-
cific threshold for lactate concentrations.
Early goal-directed resuscitation protocols used for treat-
ment of patients with sepsis and septic shock aim at reduc-
ing mortality [12]. Clinicians often use serial blood lactate 
level measurements in order to assess disease progression, 
Table 1.  Correlations Between Arterial, Peripheral Vein and Ventral Vein Lactate Values
Sites of lactate measurement Arterial Peripheral vein Central vein
Arterial
  Pearson correlation coefficient 0.880 0.898
  Significance level P < 0.0001 < 0.0001
  n 26 13
Peripheral vein
  Pearson correlation coefficient 0.880 0.941
  Significance level P < 0.0001 < 0.0001
  n 26 16
Central vein
  Pearson correlation coefficient 0.898 0.941
  Significance level P < 0.0001 < 0.0001
  n 13 16
Figure 1. Box-plot diagrams comparing arterial versus central vein versus peripheral vein lactate levels. There are no significant 
differences between the three sample sites.
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Figure 2. Linear regression analysis: peripheral blood lactate is a strong, highly significant but imperfect predictor of arterial blood 
lactate (r = 0.88, P < 0.001) (a), peripheral vein lactate is a strong, highly significant but imperfect predictor of central vein lactate 
(r = 0.94, P < 0.001) (b), and central vein lactate is a strong, highly significant but imperfect predictor of arterial blood lactate (r 
= 0.90, P < 0.001) (c).
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and arterial puncture samples are most commonly used for 
lactate level measurement in the blood gas analyzer. However, 
repeated arterial punctures cause patient discomfort or pain 
and are associated with small risk of complications, including 
damage of the artery, bleeding and arterial thrombosis with 
hand ischemia. Peripheral venous and central venous blood 
Figure 3. Bland-Altman plot shows good agreement between central vein lactate and peripheral vein lactate (a), between central 
vein lactate and arterial blood lactate (b) and between arterial blood lactate and peripheral vein lactate (c).
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samples can easily be obtained by healthcare professionals 
with various degrees of skill and experience, have lower risk 
of complications and sampling is less painful for patients. In 
cases where placement of a central line is necessary, there are 
more risks during central line insertion, but fewer disadvan-
tages afterwards.
Based on earlier publications that have demonstrated 
strong but imperfect agreement between arterial and venous 
lactate levels [6], use of peripheral vein lactate has been rec-
ommended for screening in patients with sepsis [11]. However, 
we did not identify any publications evaluating the agreement 
between arterial, venous and central venous lactate levels in 
patients with sepsis.
In conclusion, based on the strong agreement between ve-
nous, arterial and central venous lactate values in our data, it 
may be reasonable to use peripheral venous or central venous 
blood samples for measuring lactate levels in order to monitor 
disease progression and response to therapy in patients with 
sepsis. However, because this is a small, single center study, 
additional larger studies are needed to confirm or disprove the 
validity of our findings.
Acknowledgments
None to declare.
Financial Disclosure
This clinical research project was supported solely by depart-
ment funds, without any support by industry.
Conflict of Interest
All authors state that they have no conflict of interest to report.
Informed Consent
All patients (or their legal guardian) gave written informed 
consent before enrolling in the study.
Author Contributions
DV treated patients, collected data, did literature review and 
wrote the manuscript; VK treated patients, did statistical anal-
ysis and revised the manuscript; NDP collected data and did 
literature review; OK collected data and did literature review; 
CG supervised the study and revised the manuscript; MK did 
literature review, analyzed data and revised the manuscript
References
1. Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, 
Walkey AJ. Two decades of mortality trends among pa-
tients with severe sepsis: a comparative meta-analysis*. 
Crit Care Med. 2014;42(3):625-631.
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, 
Jaeschke R, Reinhart K, et al. Surviving Sepsis Campaign: 
international guidelines for management of severe sepsis 
and septic shock: 2008. Crit Care Med. 2008;36(1):296-
327.
3. Giner J, Casan P, Belda J, Gonzalez M, Miralda 
RM, Sanchis J. Pain during arterial puncture. Chest. 
1996;110(6):1443-1445.
4. Gallagher EJ, Rodriguez K, Touger M. Agreement be-
tween peripheral venous and arterial lactate levels. Ann 
Emerg Med. 1997;29(4):479-483.
5. Younger JG, Falk JL, Rothrock SG. Relationship between 
arterial and peripheral venous lactate levels. Acad Emerg 
Med. 1996;3(7):730-734.
6. Singer M, Deutschman CS, Seymour CW, Shankar-Hari 
M, Annane D, Bauer M, Bellomo R, et al. The third inter-
national consensus definitions for sepsis and septic shock 
(Sepsis-3). JAMA. 2016;315(8):801-810.
7. Hotchkiss RS, Karl IE. The pathophysiology and treat-
ment of sepsis. N Engl J Med. 2003;348(2):138-150.
8. Houwink AP, Rijkenberg S, Bosman RJ, van der Voort 
PH. The association between lactate, mean arterial pres-
sure, central venous oxygen saturation and peripheral 
temperature and mortality in severe sepsis: a retrospec-
tive cohort analysis. Crit Care. 2016;20:56.
9. Vincent JL, De Backer D. Circulatory shock. 
N Engl J Med. 2013;369(18):1726-1734.
10. Lee SM, An WS. New clinical criteria for septic shock: 
serum lactate level as new emerging vital sign. J Thorac 
Dis. 2016;8(7):1388-1390.
11. Datta D, Grahamslaw J, Gray AJ, Graham C, Walker 
CA. Lactate - Arterial and Venous Agreement in Sepsis: 
a prospective observational study. Eur J Emerg Med. 
2018;25(2):85-91.
12. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, 
Knoblich B, Peterson E, et al. Early goal-directed ther-
apy in the treatment of severe sepsis and septic shock. 
N Engl J Med. 2001;345(19):1368-1377.
